Works by Ye, Dingwei

Results: 159

Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China.

Published in:

China Oncology, 2024, v. 34, n. 11, p. 1011, doi. 10.19401/j.cnki.1007-3639.2024.11.003

By:

WANG Shanshan;
YE Dingwei;
YANG Li;
CHENG Fan;
YANG Tiejun;
ZHANG Xiaoping;
YU Zhixian;
ZHANG Qingyun;
YANG Yong

Publication type:

Article

Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity.

Published in:

Advanced Science, 2024, v. 11, n. 18, p. 1, doi. 10.1002/advs.202305724

By:

Bian, Xiaojie;
Wang, Wenfeng;
Abudurexiti, Mierxiati;
Zhang, Xingming;
Ma, Weiwei;
Shi, Guohai;
Du, Leilei;
Xu, Midie;
Wang, Xin;
Tan, Cong;
Sun, Hui;
He, Xiadi;
Zhang, Chenyue;
Zhu, Yao;
Zhang, Min;
Ye, Dingwei;
Wang, Jianhua

Publication type:

Article

circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 3537

By:

Lin, Guowen;
Sheng, Haoyue;
Xie, Huyang;
Zheng, Qiupeng;
Shen, Yijun;
Shi, Guohai;
Ye, Dingwei

Publication type:

Article

Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2677

By:

Lu, Xiaolin;
Zhang, Peipei;
Zhu, Yao;
Ye, Dingwei

Publication type:

Article

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.

Published in:

Oncology Letters, 2018, v. 16, n. 1, p. 866, doi. 10.3892/ol.2018.8782

By:

Wang, Yue;
Li, Gaoxiang;
Wan, Fangning;
Dai, Bo;
Ye, Dingwei

Publication type:

Article

Forkhead‑box series expression network is associated with outcome of clear‑cell renal cell carcinoma.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 8669, doi. 10.3892/ol.2018.8405

By:

Jia, Zhongwei;
Wan, Fangning;
Zhu, Yao;
Shi, Guohai;
Zhang, Hailiang;
Dai, Bo;
Ye, Dingwei

Publication type:

Article

SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

Published in:

Oncology Letters, 2018, v. 15, n. 4, p. 4564, doi. 10.3892/ol.2018.7828

By:

Gu, Weijie;
Wang, Beihe;
Wan, Fangning;
Wu, Junlong;
Lu, Xiaolin;
Wang, Hongkai;
Zhu, Yao;
Zhang, Hailiang;
Shi, Guohai;
Dai, Bo;
Ye, Dingwei

Publication type:

Article

Validation of the novel susceptibility loci for prostate cancer in a Chinese population.

Published in:

Oncology Letters, 2018, v. 15, n. 2, p. 2567, doi. 10.3892/ol.2017.7602

By:

Wu, Yishuo;
Chen, Haitao;
Ji, Ying;
Na, Rong;
Mo, Zengnan;
Ye, Dingwei;
Wang, Meilin;
Qi, Jun;
Lin, Xiaoling;
Ding, Qiang;
Xu, Jianfeng;
Zheng, S. Lilly;
Sun, Yinghao;
Meng, Wei

Publication type:

Article

NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.

Published in:

Oncology Letters, 2017, v. 14, n. 5, p. 6121, doi. 10.3892/ol.2017.6997

By:

YUE WANG;
FANGNING WAN;
KUN CHANG;
XIAOLIN LU;
BO DAI;
DINGWEI YE

Publication type:

Article

Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma.

Published in:

Oncology Letters, 2015, v. 10, n. 5, p. 3073, doi. 10.3892/ol.2015.3707

By:

JINYOU WANG;
JIAN LI;
JUN GU;
JIAN YU;
SHICHENG GUO;
YAO ZHU;
DINGWEI YE

Publication type:

Article

Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression.

Published in:

Cell Death & Disease, 2022, v. 13, n. 7, p. 1, doi. 10.1038/s41419-022-05086-z

By:

Wu, Tianqi;
Wang, Wenfeng;
Shi, Guohai;
Hao, Mingang;
Wang, Yingying;
Yao, Mengfei;
Huang, Yongqiang;
Du, Leilei;
Zhang, Xingming;
Ye, Dingwei;
Bian, Xiaojie;
Wang, Jianhua

Publication type:

Article

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.

Published in:

Cell Death & Disease, 2021, v. 12, n. 11, p. 1, doi. 10.1038/s41419-021-04296-1

By:

Luo, Wenjie;
Wang, Jun;
Xu, Wenhao;
Ma, Chunguang;
Wan, Fangning;
Huang, Yongqiang;
Yao, Mengfei;
Zhang, Hailiang;
Qu, Yuanyuan;
Ye, Dingwei;
Zhu, Yiping

Publication type:

Article

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.

Published in:

Cell Death & Disease, 2021, v. 12, n. 7, p. 1, doi. 10.1038/s41419-021-03947-7

By:

Wang, Yuchen;
Wu, Jie;
Luo, Wenjie;
Zhang, Hailiang;
Shi, Guohai;
Shen, Yijun;
Zhu, Yao;
Ma, Chunguang;
Dai, Bo;
Ye, Dingwei;
Zhu, Yiping

Publication type:

Article

LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.

Published in:

Cell Death & Disease, 2020, v. 11, n. 8, p. 1, doi. 10.1038/s41419-020-02856-5

By:

Yao, Mengfei;
Shi, Xiaolei;
Li, Yue;
Xiao, Yutian;
Butler, William;
Huang, Yongqiang;
Du, Leilei;
Wu, Tianqi;
Bian, Xiaojie;
Shi, Guohai;
Ye, Dingwei;
Fu, Guohui;
Wang, Jianhua;
Ren, Shancheng

Publication type:

Article

Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 61, doi. 10.2147/OTT.S96294

By:

Guiming Zhang;
Yao Zhu;
Fang Liu;
Chengyuan Gu;
Haitao Chen;
Jianfeng Xu;
Dingwei Ye

Publication type:

Article

Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study.

Published in:

OncoTargets & Therapy, 2015, v. 8, p. 1363, doi. 10.2147/OTT.S83302

By:

Shukui Qin;
Feng Bi;
Jie Jin;
Ying Cheng;
Jun Guo;
Xiubao Ren;
Yiran Huang;
Tarazi, Jamal;
Jie Tang;
Connie Chen;
Sinil Kim;
Dingwei Ye

Publication type:

Article

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

Published in:

OncoTargets & Therapy, 2014, v. 7, p. 2043, doi. 10.2147/OTT.S70012

By:

Guiming Zhang;
Yao Zhu;
Dahai Dong;
Weijie Gu;
Hailiang Zhang;
Lijiang Sun;
Dingwei Ye

Publication type:

Article

Fruquintinib Plus Sintilimab in Patients with Treatment-Naive and Previously Treated Advanced Renal Cell Carcinoma: Results from a Phase Ib/II Clinical Trial: Fruquintinib Plus Sintilimab in Patients with Advanced Renal Cell Carcinoma: H. Xu et al.

Published in:

Targeted Oncology, 2025, v. 20, n. 1, p. 113, doi. 10.1007/s11523-024-01120-6

By:

Xu, Hua;
Yao, Xin;
He, Zhisong;
Luo, Hong;
Li, Guiling;
Guo, Jianming;
Diao, Lei;
Fan, Yu;
Li, Yuan;
Fan, Jiquan;
Hu, Xiaoyi;
Lu, Puhan;
Shi, Haiyan;
Chen, Keyan;
Tan, Panfeng;
Fan, Songhua;
Shi, Michael;
Su, Weiguo;
Ye, Dingwei

Publication type:

Article

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 639, doi. 10.1007/s11523-023-00987-1

By:

Motzer, Robert J.;
Russo, Paul;
Grünwald, Viktor;
Tomita, Yoshihiko;
Zurawski, Bogdan;
Parikh, Omi;
Buti, Sebastiano;
Barthélémy, Philippe;
Goh, Jeffrey C.;
Ye, Dingwei;
Lingua, Alejo;
Lattouf, Jean-Baptiste;
Albigès, Laurence;
George, Saby;
Shuch, Brian;
Sosman, Jeffrey;
Staehler, Michael;
Vázquez Estévez, Sergio;
Simsek, Burcin;
Spiridigliozzi, Julia

Publication type:

Article

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.

Published in:

Nature Genetics, 2012, v. 44, n. 11, p. 1231, doi. 10.1038/ng.2424

By:

Xu, Jianfeng;
Mo, Zengnan;
Ye, Dingwei;
Wang, Meilin;
Liu, Fang;
Jin, Guangfu;
Xu, Chuanliang;
Wang, Xiang;
Shao, Qiang;
Chen, Zhiwen;
Tao, Zhihua;
Qi, Jun;
Zhou, Fangjian;
Wang, Zhong;
Fu, Yaowen;
He, Dalin;
Wei, Qiang;
Guo, Jianming;
Wu, Denglong;
Gao, Xin

Publication type:

Article

Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01729-7

By:

Yang, Kaiwei;
Hu, Hailong;
Wu, Junlong;
Wang, Huina;
Guo, Zhaoxia;
Yu, Wei;
Yao, Lin;
Ding, Feng;
Zhou, Tao;
Wang, Wang;
Wang, Yunkai;
Liu, Lei;
Guo, Jing;
Zhu, Shuaipeng;
Zhang, Xinhao;
Cao, Shanbo;
Lou, Feng;
Niu, Yuanjie;
Ye, Dingwei;
He, Zhisong

Publication type:

Article

Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17451, doi. 10.1007/s00432-023-05259-z

By:

Tian, Xi;
Zhu, Shuxuan;
Liu, Wangrui;
Wu, Xinrui;
Wei, Gaomeng;
Zhang, Ji;
Anwaier, Aihetaimujiang;
chen, Cong;
Ye, Shiqi;
Che, Xiangxian;
Xu, Wenhao;
Qu, Yuanyuan;
Zhang, Hailiang;
Ye, Dingwei

Publication type:

Article

Role of KIT expression in the prognosis of clear cell renal cell carcinomas in Chinese patients.

Published in:

Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 2, p. 249, doi. 10.1007/s00432-008-0447-6

By:

Hailiang Zhang;
Dingwei Ye;
Xudong Yao;
Bo Dai;
Shilin Zhang;
Yijun Shen;
Yao Zhu;
Huirong Mao

Publication type:

Article

Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1541, doi. 10.1007/s00262-022-03347-6

By:

Fang, Bangwei;
Wei, Yu;
Zeng, Hao;
Li, Yonghong;
Chen, Shouzhen;
Zhang, Tingwei;
Pan, Jian;
Wang, Beihe;
Wu, Junlong;
Jin, Shengming;
Gan, Hualei;
Hu, Mengna;
Zhang, Ding;
Ye, Dingwei;
Zhu, Yao

Publication type:

Article

Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1923, doi. 10.1007/s00262-021-03123-y

By:

Xu, Wenhao;
Ma, Chunguang;
Liu, Wangrui;
Anwaier, Aihetaimujiang;
Tian, Xi;
Shi, Guohai;
Qu, Yuanyuan;
Wei, Shiyin;
Zhang, Hailiang;
Ye, Dingwei

Publication type:

Article

Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer.

Published in:

2014

By:

Wang, Xiaofang;
Li, Lihui;
Liang, Yupei;
Li, Chunjie;
Zhao, Hu;
Ye, Dingwei;
Sun, Menghong;
Jeong, Lak Shin;
Feng, Yan;
Fu, Shen;
Jia, Lijun;
Guo, Xiaomao

Publication type:

Journal Article

Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer.

Published in:

BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/974309

By:

Xiaofang Wang;
Lihui Li;
Yupei Liang;
Chunjie Li;
Hu Zhao;
Dingwei Ye;
Menghong Sun;
Lak Shin Jeong;
Yan Feng;
Shen Fu;
Lijun Jia;
Xiaomao Guo

Publication type:

Article

SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition.

Published in:

Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26049-6

By:

Ma, Jian;
Shi, Qing;
Cui, Gaofeng;
Sheng, Haoyue;
Botuyan, Maria Victoria;
Zhou, Yingke;
Yan, Yuqian;
He, Yundong;
Wang, Liguo;
Wang, Yuzhuo;
Mer, Georges;
Ye, Dingwei;
Wang, Chenji;
Huang, Haojie

Publication type:

Article

A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.

Published in:

Cell Death & Disease, 2024, v. 15, n. 4, p. 1, doi. 10.1038/s41419-024-06665-y

By:

Wang, Yichen;
Nan, Yanyang;
Ma, Chunguang;
Lu, Xiaolin;
Wang, Qian;
Huang, Xiting;
Xue, Wenjing;
Fan, Jiajun;
Ju, Dianwen;
Ye, Dingwei;
Zhang, Xuyao

Publication type:

Article

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 596, doi. 10.1080/07853890.2021.1908588

By:

Xu, Wenhao;
Anwaier, Aihetaimujiang;
Ma, Chunguang;
Liu, Wangrui;
Tian, Xi;
Palihati, Maierdan;
Hu, Xiaoxin;
Qu, Yuanyuan;
Zhang, Hailiang;
Ye, Dingwei

Publication type:

Article

Multi-omics reveals novel prognostic implication of SRC protein expression in bladder cancer and its correlation with immunotherapy response.

Published in:

Annals of Medicine, 2021, v. 53, n. 1, p. 596, doi. 10.1080/07853890.2021.1908588

By:

Wenhao Xu;
Aihetaimujiang Anwaier;
Chunguang Ma;
Wangrui Liu;
Xi Tian;
Maierdan Palihati;
Xiaoxin Hu;
Yuanyuan Qu;
Hailiang Zhang;
Dingwei Ye

Publication type:

Article

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml.

Published in:

PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130308

By:

Chen, Rui;
Huang, Yiran;
Cai, Xiaobing;
Xie, Liping;
He, Dalin;
Zhou, Liqun;
Xu, Chuanliang;
Gao, Xu;
Ren, Shancheng;
Wang, Fubo;
Ma, Lulin;
Wei, Qiang;
Yin, Changjun;
Tian, Ye;
Sun, Zhongquan;
Fu, Qiang;
Ding, Qiang;
Zheng, Junhua;
Ye, Zhangqun;
Ye, Dingwei

Publication type:

Article

Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer.

Published in:

PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120159

By:

Bian, Xiaojie;
Shen, Yijun;
Zhang, Guiming;
Gu, Chenyuan;
Cai, Ying;
Wang, Chaofu;
Zhu, Yiping;
Zhu, Yao;
Zhang, Hailiang;
Dai, Bo;
Ye, Dingwei

Publication type:

Article

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series.

Published in:

PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118022

By:

Gu, Weijie;
Zhu, Yao;
Wang, Hongkai;
Zhang, Hailiang;
Shi, Guohai;
Liu, Xiaohang;
Ye, Dingwei

Publication type:

Article

Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.

Published in:

2019

By:

Wu, Junlong;
Wang, Hongkai;
Ricketts, Christopher J.;
Yang, Youfeng;
Merino, Maria J.;
Zhang, Hailiang;
Shi, Guohai;
Gan, Hualei;
Linehan, W. Marston;
Zhu, Yao;
Ye, Dingwei

Publication type:

journal article

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.

Published in:

Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01390-4

By:

Wu, Gengrun;
Li, Teng;
Chen, Yuanbiao;
Ye, Shiqi;
Zhou, Siqi;
Tian, Xi;
Anwaier, Aihetaimujiang;
Zhu, Shuxuan;
Xu, Wenhao;
Hao, Xiaohang;
Ye, Dingwei;
Zhang, Hailiang

Publication type:

Article

Tertiary Lymphoid Structures Localization and Maturation Heterogeneities Correlate with Divergent Microenvironment Features and Immune Responses of Clear Cell Renal Cell Carcinoma.

Published in:

Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 227, doi. 10.36401/JIPO-24-X2

By:

Jiahe Lu;
Wenhao Xu;
Hailiang Zhang;
Dingwei Ye

Publication type:

Article

Comprehensive Collection of Whole-Slide Images and Genomic Profiles for Patients with Bladder Cancer.

Published in:

Scientific Data, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41597-024-03526-3

By:

Xu, Pei-Hang;
Li, Tianqi;
Qu, Fengmei;
Tian, Mingkang;
Wang, Jun;
Gan, Hualei;
Ye, Dingwei;
Ren, Fei;
Shen, Yijun

Publication type:

Article

Detection, molecular function and mechanisms of m5C in cancer.

Published in:

Clinical & Translational Medicine, 2025, v. 15, n. 3, p. 1, doi. 10.1002/ctm2.70239

By:

Zhang, Linhui;
Li, Yuelong;
Li, Liqing;
Yao, Fei;
Cai, Maoping;
Ye, Dingwei;
Qu, Yuanyuan

Publication type:

Article

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.

Published in:

Clinical & Translational Medicine, 2023, v. 13, n. 9, p. 1, doi. 10.1002/ctm2.1411

By:

Zhang, Tingwei;
Wei, Yu;
Hong, Boon Hao;
Sumiyoshi, Takayuki;
Ong, Enya Hui Wen;
Zeng, Hao;
Li, Yonghong;
Ng, Chi‐Fai;
Pan, Jian;
Fang, Bangwei;
Wang, Beihe;
Wu, Junlong;
Wang, Hongkai;
Akamatsu, Shusuke;
Chua, Melvin Lee Kiang;
Ye, Dingwei;
Zhu, Yao

Publication type:

Article

Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression.

Published in:

Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1028

By:

Zhu, Wenkai;
Wan, Fangning;
Xu, Wenhao;
Liu, Zheng;
Wang, Junjie;
Zhang, Hena;
Huang, Shenglin;
Ye, Dingwei

Publication type:

Article

Adenylate cyclase‐activating polypeptide 1 gene methylation predicts prognosis and the immune microenvironment of bladder cancer.

Published in:

Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.597

By:

Xu, Wenhao;
Anwaier, Aihetaimujiang;
Liu, Wangrui;
Tian, Xi;
Qu, Yuanyuan;
Zhao, Jianyuan;
Zhang, Hailiang;
Ye, Dingwei

Publication type:

Article

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma.

Published in:

Clinical & Translational Medicine, 2020, v. 10, n. 3, p. 1, doi. 10.1002/ctm2.120

By:

Zeng, Bohan;
Huang, Yongqiang;
Jin, Shengming;
Zhang, Xuanzhi;
Zhang, Hailiang;
Shi, Guohai;
Cao, Dalong;
Chang, Kun;
Dai, Bo;
Ye, Dingwei

Publication type:

Article

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.

Published in:

BJU International, 2020, v. 125, n. 4, p. 541, doi. 10.1111/bju.14980

By:

Uemura, Hirotsugu;
Ye, Dingwei;
Kanesvaran, Ravindran;
Chiong, Edmund;
Lojanapiwat, Bannakij;
Pu, Yeong‐Shiau;
Rawal, Sudhir Kumar;
Abdul Razack, Azad Hassan;
Zeng, Hao;
Chung, Byung Ha;
Md Yusoff, Noor Ashani;
Ohyama, Chikara;
Kim, Choung Soo;
Leewansangtong, Sunai;
Tsai, Yuh‐Shyan;
Liu, Yanfang;
Liu, Weiping;
Kooten Losio, Maximiliano;
Asinas‐Tan, Marxengel

Publication type:

Article

Reconstruction with scrotal skin flaps after wide local resection of penoscrotal extramammary Paget's disease.

Published in:

BJU International, 2012, v. 110, n. 11c, p. E1121, doi. 10.1111/j.1464-410X.2012.11491.x

By:

Qin, XiaoJian;
Zhang, Shilin;
Zhang, HaiLiang;
Shen, YiJun;
Zhu, Yao;
Ye, DingWei

Publication type:

Article

Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.

Published in:

BJU International, 2012, v. 110, n. 11b, p. E667, doi. 10.1111/j.1464-410X.2012.11465.x

By:

Dai, Bo;
Qu, YuanYuan;
Kong, YunYi;
Ye, DingWei;
Yao, XuDong;
Zhang, ShiLin;
Wang, ChaoFu;
Zhang, HaiLiang;
Yang, WeiYi

Publication type:

Article

CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1498579

By:

Lu, Xiaolin;
Ge, Li-Ping;
Liu, Zhaopei;
Zhu, Yu;
Ye, Dingwei;
Chang, Yuan

Publication type:

Article

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma.

Published in:

Cancer Science, 2021, v. 112, n. 1, p. 305, doi. 10.1111/cas.14681

By:

Ye, Dingwei;
Liu, Jiyan;
Zhou, Aiping;
Zou, Qing;
Li, Hanzhong;
Fu, Cheng;
Hu, Hailong;
Huang, Jian;
Zhu, Shaoxing;
Jin, Jie;
Ma, Lulin;
Guo, Jianming;
Xiao, Jun;
Park, Se Hoon;
Zhang, Dahong;
Qiu, Xiusong;
Bao, Yuanyuan;
Zhang, Lilin;
Shen, Wei;
Bi, Feng

Publication type:

Article

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.

Published in:

Cancer Science, 2015, v. 106, n. 6, p. 687, doi. 10.1111/cas.12664

By:

Zhang, Guiming;
Gu, Chengyuan;
Zhu, Yao;
Luo, Lei;
Dong, Dahai;
Wan, Fangning;
Zhang, Hailiang;
Shi, Guohai;
Sun, Lijiang;
Ye, Dingwei

Publication type:

Article

Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer.

Published in:

World Journal of Urology, 2019, v. 37, n. 10, p. 2165, doi. 10.1007/s00345-018-2603-1

By:

Huang, Yongqiang;
Sheng, Haoyue;
Zhang, Junyu;
Liu, Qi;
Ye, Dingwei;
Shi, Guohai

Publication type:

Article